{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T08:18:52Z","timestamp":1774685932638,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 108-2314-B-038-105"],"award-info":[{"award-number":["MOST 108-2314-B-038-105"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST-109-2314-B-038-130"],"award-info":[{"award-number":["MOST-109-2314-B-038-130"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["MOHW109-TDU-B-212-124020"],"award-info":[{"award-number":["MOHW109-TDU-B-212-124020"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"publisher","award":["109-TMU-WFH-05"],"award-info":[{"award-number":["109-TMU-WFH-05"]}],"id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"publisher","award":["DP2-107-21121-C-04"],"award-info":[{"award-number":["DP2-107-21121-C-04"]}],"id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gastric Cancer"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s10120-020-01154-5","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T20:02:49Z","timestamp":1611950569000},"page":"624-639","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer"],"prefix":"10.1007","volume":"24","author":[{"given":"Chung-Chi","family":"Hsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Ying","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwang-Yu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tze-Sian","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Jui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Ting","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Shen","family":"Shan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin-Hsin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tai-Yan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1612-2868","authenticated-orcid":false,"given":"Kelvin K.","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,29]]},"reference":[{"issue":"5","key":"1154_CR1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359\u201386.","journal-title":"Int J Cancer"},{"issue":"11","key":"1154_CR2","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/S1470-2045(14)70420-6","volume":"15","author":"H Wilke","year":"2014","unstructured":"Wilke H, Muro K, Van Cutsem E, Oh SC, Bodoky G, Shimada Y, et al. Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial. Lancet Oncol. 2014;15(11):1224\u201335.","journal-title":"Lancet Oncol"},{"issue":"6","key":"1154_CR3","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S1470-2045(16)00175-3","volume":"17","author":"K Muro","year":"2016","unstructured":"Muro K, Chung HC, Shankaran V, Geva R, Catenacci D, Gupta S, et al. Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial. Lancet Oncol. 2016;17(6):717\u201326.","journal-title":"Lancet Oncol"},{"issue":"10111","key":"1154_CR4","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/S0140-6736(17)31827-5","volume":"390","author":"YK Kang","year":"2017","unstructured":"Kang YK, Boku N, Satoh T, Ryu MH, Chao Y, Kato K, et al. Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2017;390(10111):2461\u201371.","journal-title":"Lancet"},{"issue":"6349","key":"1154_CR5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.aan6733","volume":"357","author":"DT Le","year":"2017","unstructured":"Le DT, Durham JN, Smith KN, Wang H, Bartlett BR, Aulakh LK, et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science. 2017;357(6349):409\u201313.","journal-title":"Science"},{"issue":"7035","key":"1154_CR6","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nature03319","volume":"434","author":"T Reya","year":"2005","unstructured":"Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature. 2005;434(7035):843\u201350.","journal-title":"Nature"},{"issue":"7187","key":"1154_CR7","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nature06835","volume":"452","author":"I Malanchi","year":"2008","unstructured":"Malanchi I, Peinado H, Kassen D, Hussenet T, Metzger D, Chambon P, et al. Cutaneous cancer stem cell maintenance is dependent on beta-catenin signalling. Nature. 2008;452(7187):650\u20133.","journal-title":"Nature"},{"issue":"26","key":"1154_CR8","doi-asserted-by":"crossref","first-page":"15853","DOI":"10.1073\/pnas.2136825100","volume":"100","author":"Y Li","year":"2003","unstructured":"Li Y, Welm B, Podsypanina K, Huang S, Chamorro M, Zhang X, et al. Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc Natl Acad Sci USA. 2003;100(26):15853\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"1154_CR9","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1053\/j.gastro.2008.06.089","volume":"135","author":"PW Heiser","year":"2008","unstructured":"Heiser PW, Cano DA, Landsman L, Kim GE, Kench JG, Klimstra DS, et al. Stabilization of beta-catenin induces pancreas tumor formation. Gastroenterology. 2008;135(4):1288\u2013300.","journal-title":"Gastroenterology"},{"issue":"6","key":"1154_CR10","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/ng.2983","volume":"46","author":"K Wang","year":"2014","unstructured":"Wang K, Yuen ST, Xu J, Lee SP, Yan HH, Shi ST, et al. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat Genet. 2014;46(6):573\u201382.","journal-title":"Nat Genet"},{"issue":"24","key":"1154_CR11","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1111\/bph.13890","volume":"174","author":"DJ Flanagan","year":"2017","unstructured":"Flanagan DJ, Vincan E, Phesse TJ. Winding back Wnt signalling: potential therapeutic targets for treating gastric cancers. Br J Pharmacol. 2017;174(24):4666\u201383.","journal-title":"Br J Pharmacol"},{"issue":"15","key":"1154_CR12","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1093\/hmg\/ddi220","volume":"14","author":"N Kouprina","year":"2005","unstructured":"Kouprina N, Pavlicek A, Collins NK, Nakano M, Noskov VN, Ohzeki J, et al. The microcephaly ASPM gene is expressed in proliferating tissues and encodes for a mitotic spindle protein. Hum Mol Genet. 2005;14(15):2155\u201365.","journal-title":"Hum Mol Genet"},{"issue":"10","key":"1154_CR13","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/bjc.2011.117","volume":"104","author":"A Bruning-Richardson","year":"2011","unstructured":"Bruning-Richardson A, Bond J, Alsiary R, Richardson J, Cairns DA, McCormack L, et al. ASPM and microcephalin expression in epithelial ovarian cancer correlates with tumour grade and survival. Br J Cancer. 2011;104(10):1602\u201310.","journal-title":"Br J Cancer"},{"key":"1154_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2867-10-1","volume":"10","author":"SN Bikeye","year":"2010","unstructured":"Bikeye SN, Colin C, Marie Y, Vampouille R, Ravassard P, Rousseau A, et al. ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic target. Cancer Cell Int. 2010;10:1.","journal-title":"Cancer Cell Int"},{"issue":"15","key":"1154_CR15","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1158\/1078-0432.CCR-07-5262","volume":"14","author":"SY Lin","year":"2008","unstructured":"Lin SY, Pan HW, Liu SH, Jeng YM, Hu FC, Peng SY, et al. ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma. Clin Cancer Res. 2008;14(15):4814\u201320.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1154_CR16","first-page":"1865","volume":"17","author":"Z Xu","year":"2019","unstructured":"Xu Z, Zhang Q, Luh F, Jin B, Liu X. Overexpression of the ASPM gene is associated with aggressiveness and poor outcome in bladder cancer. Oncol Lett. 2019;17(2):1865\u201376.","journal-title":"Oncol Lett"},{"issue":"5","key":"1154_CR17","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1053\/j.gastro.2013.07.040","volume":"145","author":"WY Wang","year":"2013","unstructured":"Wang WY, Hsu CC, Wang TY, Li CR, Hou YC, Chu JM, et al. A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression. Gastroenterology. 2013;145(5):1110\u201320.","journal-title":"Gastroenterology"},{"key":"1154_CR18","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/s41388-018-0497-4","volume":"38","author":"VC Pai","year":"2019","unstructured":"Pai VC, Hsu CC, Chan TS, Liao WY, Chuu CP, Chen WY, et al. ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-beta-catenin signaling. Oncogene. 2019;38:1340\u201353.","journal-title":"Oncogene"},{"issue":"3","key":"1154_CR19","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.stemcr.2020.02.003","volume":"14","author":"WY Liao","year":"2020","unstructured":"Liao WY, Hsu CC, Chan TS, Yen CJ, Chen WY, Pan HW, et al. Dishevelled 1-regulated superpotent cancer stem cells mediate Wnt heterogeneity and tumor progression in hepatocellular carcinoma. Stem Cell Rep. 2020;14(3):462\u201377.","journal-title":"Stem Cell Rep"},{"issue":"4","key":"1154_CR20","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/path.5341","volume":"249","author":"CC Hsu","year":"2019","unstructured":"Hsu CC, Liao WY, Chan TS, Chen WY, Lee CT, Shan YS, et al. The differential distributions of ASPM isoforms and their roles in Wnt signaling, cell cycle progression, and pancreatic cancer prognosis. J Pathol. 2019;249(4):498\u2013508.","journal-title":"J Pathol"},{"issue":"4","key":"1154_CR21","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/path.4591","volume":"237","author":"P Vange","year":"2015","unstructured":"Vange P, Bruland T, Beisvag V, Erlandsen SE, Flatberg A, Doseth B, et al. Genome-wide analysis of the oxyntic proliferative isthmus zone reveals ASPM as a possible gastric stem\/progenitor cell marker over-expressed in cancer. J Pathol. 2015;237(4):447\u201359.","journal-title":"J Pathol"},{"issue":"3","key":"1154_CR22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/14728222.2020.1727888","volume":"24","author":"S Borhani","year":"2020","unstructured":"Borhani S, Gartel AL. FOXM1: a potential therapeutic target in human solid cancers. Expert Opin Ther Targets. 2020;24(3):205\u201317.","journal-title":"Expert Opin Ther Targets"},{"issue":"6436","key":"1154_CR23","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/364412a0","volume":"364","author":"KL Clark","year":"1993","unstructured":"Clark KL, Halay ED, Lai E, Burley SK. Co-crystal structure of the HNF-3\/fork head DNA-recognition motif resembles histone H5. Nature. 1993;364(6436):412\u201320.","journal-title":"Nature"},{"issue":"3","key":"1154_CR24","doi-asserted-by":"crossref","first-page":"396","DOI":"10.4161\/cc.10.3.14709","volume":"10","author":"TV Kalin","year":"2011","unstructured":"Kalin TV, Ustiyan V, Kalinichenko VV. Multiple faces of FoxM1 transcription factor: lessons from transgenic mouse models. Cell Cycle. 2011;10(3):396\u2013405.","journal-title":"Cell Cycle"},{"issue":"7","key":"1154_CR25","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1101\/gad.1200704","volume":"18","author":"VV Kalinichenko","year":"2004","unstructured":"Kalinichenko VV, Major ML, Wang X, Petrovic V, Kuechle J, Yoder HM, et al. Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor. Genes Dev. 2004;18(7):830\u201350.","journal-title":"Genes Dev"},{"issue":"2","key":"1154_CR26","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/ncb1217","volume":"7","author":"J Laoukili","year":"2005","unstructured":"Laoukili J, Kooistra MR, Bras A, Kauw J, Kerkhoven RM, Morrison A, et al. FoxM1 is required for execution of the mitotic programme and chromosome stability. Nat Cell Biol. 2005;7(2):126\u201336.","journal-title":"Nat Cell Biol"},{"issue":"4","key":"1154_CR27","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ccr.2011.08.016","volume":"20","author":"N Zhang","year":"2011","unstructured":"Zhang N, Wei P, Gong A, Chiu WT, Lee HT, Colman H, et al. FoxM1 promotes beta-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis. Cancer Cell. 2011;20(4):427\u201342.","journal-title":"Cancer Cell"},{"issue":"1","key":"1154_CR28","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/s41467-020-14590-9","volume":"11","author":"Y Sheng","year":"2020","unstructured":"Sheng Y, Yu C, Liu Y, Hu C, Ma R, Lu X, et al. FOXM1 regulates leukemia stem cell quiescence and survival in MLL-rearranged AML. Nat Commun. 2020;11(1):928.","journal-title":"Nat Commun"},{"key":"1154_CR29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/1476-4598-12-159","volume":"12","author":"M Quan","year":"2013","unstructured":"Quan M, Wang P, Cui J, Gao Y, Xie K. The roles of FOXM1 in pancreatic stem cells and carcinogenesis. Mol Cancer. 2013;12:159.","journal-title":"Mol Cancer"},{"key":"1154_CR30","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/1479-5876-11-204","volume":"11","author":"X Li","year":"2013","unstructured":"Li X, Qiu W, Liu B, Yao R, Liu S, Yao Y, et al. Forkhead box transcription factor 1 expression in gastric cancer: FOXM1 is a poor prognostic factor and mediates resistance to docetaxel. J Transl Med. 2013;11:204.","journal-title":"J Transl Med"},{"issue":"17","key":"1154_CR31","doi-asserted-by":"crossref","first-page":"9613","DOI":"10.1111\/jcmm.15435","volume":"24","author":"WJ Zeng","year":"2020","unstructured":"Zeng WJ, Cheng Q, Wen ZP, Wang JY, Chen YH, Zhao J, et al. Aberrant ASPM expression mediated by transcriptional regulation of FoxM1 promotes the progression of gliomas. J Cell Mol Med. 2020;24(17):9613\u201326.","journal-title":"J Cell Mol Med"},{"issue":"7","key":"1154_CR32","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M Al-Hajj","year":"2003","unstructured":"Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 2003;100(7):3983\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"1154_CR33","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1158\/0008-5472.CAN-06-2030","volume":"67","author":"C Li","year":"2007","unstructured":"Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, et al. Identification of pancreatic cancer stem cells. Cancer Res. 2007;67(3):1030\u20137.","journal-title":"Cancer Res"},{"issue":"7","key":"1154_CR34","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/onc.2013.23","volume":"33","author":"MD Arensman","year":"2014","unstructured":"Arensman MD, Kovochich AN, Kulikauskas RM, Lay AR, Yang PT, Li X, et al. WNT7B mediates autocrine Wnt\/beta-catenin signaling and anchorage-independent growth in pancreatic adenocarcinoma. Oncogene. 2014;33(7):899\u2013908.","journal-title":"Oncogene"},{"issue":"13","key":"1154_CR35","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/sim.1802","volume":"23","author":"MJ Pencina","year":"2004","unstructured":"Pencina MJ, D\u2019Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med. 2004;23(13):2109\u201323.","journal-title":"Stat Med"},{"issue":"2","key":"1154_CR36","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/path.5355","volume":"250","author":"M Timaner","year":"2020","unstructured":"Timaner M, Shaked Y. Elucidating the roles of ASPM isoforms reveals a novel prognostic marker for pancreatic cancer. J Pathol. 2020;250(2):123\u20135.","journal-title":"J Pathol"},{"issue":"18","key":"1154_CR37","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1101\/gad.16830211","volume":"25","author":"JJ Buchman","year":"2011","unstructured":"Buchman JJ, Durak O, Tsai LH. ASPM regulates Wnt signaling pathway activity in the developing brain. Genes Dev. 2011;25(18):1909\u201314.","journal-title":"Genes Dev"},{"issue":"6","key":"1154_CR38","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.celrep.2016.06.092","volume":"16","author":"X Jin","year":"2016","unstructured":"Jin X, Jeon HM, Jin X, Kim EJ, Yin J, Jeon HY, et al. The ID1-CULLIN3 axis regulates intracellular SHH and WNT signaling in glioblastoma stem cells. Cell Rep. 2016;16(6):1629\u201341.","journal-title":"Cell Rep"},{"issue":"6","key":"1154_CR39","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1158\/1078-0432.CCR-15-2157","volume":"23","author":"PH Nguyen","year":"2017","unstructured":"Nguyen PH, Giraud J, Chambonnier L, Dubus P, Wittkop L, Belleannee G, et al. Characterization of biomarkers of tumorigenic and chemoresistant cancer stem cells in human gastric carcinoma. Clin Cancer Res. 2017;23(6):1586\u201397.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1154_CR40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.stem.2009.11.013","volume":"6","author":"N Barker","year":"2010","unstructured":"Barker N, Huch M, Kujala P, van de Wetering M, Snippert HJ, van Es JH, et al. Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell. 2010;6(1):25\u201336.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"1154_CR41","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nm.3850","volume":"21","author":"R Cristescu","year":"2015","unstructured":"Cristescu R, Lee J, Nebozhyn M, Kim KM, Ting JC, Wong SS, et al. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med. 2015;21(5):449\u201356.","journal-title":"Nat Med"},{"issue":"9742","key":"1154_CR42","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","volume":"376","author":"YJ Bang","year":"2010","unstructured":"Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010;376(9742):687\u201397.","journal-title":"Lancet"},{"issue":"9","key":"1154_CR43","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/s41591-018-0101-z","volume":"24","author":"ST Kim","year":"2018","unstructured":"Kim ST, Cristescu R, Bass AJ, Kim KM, Odegaard JI, Kim K, et al. Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer. Nat Med. 2018;24(9):1449\u201358.","journal-title":"Nat Med"},{"issue":"7494","key":"1154_CR44","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature13187","volume":"508","author":"AS Cleary","year":"2014","unstructured":"Cleary AS, Leonard TL, Gestl SA, Gunther EJ. Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers. Nature. 2014;508(7494):113\u20137.","journal-title":"Nature"},{"issue":"5","key":"1154_CR45","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/ncb2048","volume":"12","author":"L Vermeulen","year":"2010","unstructured":"Vermeulen L, De Sousa EMF, van der Heijden M, Cameron K, de Jong JH, Borovski T, et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol. 2010;12(5):468\u201376.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"1154_CR46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc3419","volume":"13","author":"JN Anastas","year":"2013","unstructured":"Anastas JN, Moon RT. WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer. 2013;13(1):11\u201326.","journal-title":"Nat Rev Cancer"}],"updated-by":[{"DOI":"10.1007\/s10120-021-01185-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T00:00:00Z","timestamp":1616716800000}}],"container-title":["Gastric Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-020-01154-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10120-020-01154-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-020-01154-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T01:12:06Z","timestamp":1643418726000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10120-020-01154-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,29]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["1154"],"URL":"https:\/\/doi.org\/10.1007\/s10120-020-01154-5","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s10120-021-01185-6","asserted-by":"object"}]},"ISSN":["1436-3291","1436-3305"],"issn-type":[{"value":"1436-3291","type":"print"},{"value":"1436-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,29]]},"assertion":[{"value":"26 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10120-021-01185-6","URL":"https:\/\/doi.org\/10.1007\/s10120-021-01185-6","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no potential conflict that is relevant to the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}